Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model
Kai Liu1*, Guangqing Cao1*, Xiquan Zhang1, Ruifang Liu2, Weiwei Zou3, Shuming Wu11Departments of Cardiovascular Surgery, 2Anesthesia, Qilu Hospital of Shandong University, Jinan; 3The School of Pharmaceutical Science, Shandong University, Jinan, Shandong, People’s Republic of China; *K...
Main Authors: | Kai Liu, Guangqing Cao, Xiquan Zhang, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-10-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/pretreatment-with-intraluminal-rapamycin-nanoparticle-perfusion-inhibi-a5481 |
Similar Items
-
Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
by: Ma Hao, et al.
Published: (2011-05-01) -
Retraction: Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
by: Zou Junjie, et al.
Published: (2012-03-01) -
Multiscale, patient-specific computational fluid dynamics models predict formation of neointimal hyperplasia in saphenous vein grafts
by: Francesca Donadoni, MRes, et al.
Published: (2020-06-01) -
The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model
by: Guzeloglu Mehmet, et al.
Published: (2012-06-01) -
Perivascular mast cells regulate vein graft neointimal formation and remodeling
by: Junxi Wu, et al.
Published: (2015-08-01)